[HTML][HTML] Prognostic and predictive biomarkers in gliomas
P Śledzińska, MG Bebyn, J Furtak… - International journal of …, 2021 - mdpi.com
Gliomas are the most common central nervous system tumors. New technologies, including
genetic research and advanced statistical methods, revolutionize the therapeutic approach …
genetic research and advanced statistical methods, revolutionize the therapeutic approach …
[HTML][HTML] Combining amino acid PET and MRI imaging increases accuracy to define malignant areas in adult glioma
…, J Rakowska, M Harat, T Szylberg, J Furtak… - Nature …, 2023 - nature.com
Accurate determination of the extent and grade of adult-type diffuse gliomas is critical to
patient management. In clinical practice, contrast-enhancing areas of diffuse gliomas in …
patient management. In clinical practice, contrast-enhancing areas of diffuse gliomas in …
[HTML][HTML] New chemical biopsy tool for spatially resolved profiling of human brain tissue in vivo
It is extremely challenging to perform chemical analyses of the brain, particularly in humans,
due to the restricted access to this organ. Imaging techniques are the primary approach …
due to the restricted access to this organ. Imaging techniques are the primary approach …
[HTML][HTML] MGMT Promoter Methylation as a Prognostic Factor in Primary Glioblastoma: A Single-Institution Observational Study
…, M Birski, M Harat, R Włodarski, J Furtak - Biomedicines, 2022 - mdpi.com
Glioblastoma is the most malignant central nervous system tumor, which represents 50% of
all glial tumors. The understanding of glioma genesis, prognostic evaluation, and treatment …
all glial tumors. The understanding of glioma genesis, prognostic evaluation, and treatment …
Quality of YouTube videos on meningioma treatment using the DISCERN instrument
P Śledzińska, MG Bebyn, J Furtak - World Neurosurgery, 2021 - Elsevier
Objective To assess the quality of YouTube videos on meningioma treatment. Methods A
search was performed on YouTube using the keywords “meningioma treatment,” “meningeal …
search was performed on YouTube using the keywords “meningioma treatment,” “meningeal …
[HTML][HTML] Glioma 2021 WHO classification: the superiority of NGS over IHC in routine diagnostics
P Śledzińska, M Bebyn, E Szczerba, J Furtak… - Molecular Diagnosis & …, 2022 - Springer
Introduction The accurate detection of genetic variants such as single substitutions (IDH1/2,
TERT), chromosomal abnormalities (CDKN2A, 1p/19q deletions, and EGFR amplifications), …
TERT), chromosomal abnormalities (CDKN2A, 1p/19q deletions, and EGFR amplifications), …
Motor cortex stimulation in patients with chronic central pain.
P Sokal, M Harat, P Zieliński, J Furtak… - Advances in clinical …, 2015 - europepmc.org
Motor cortex stimulation in patients with chronic central pain. - Abstract - Europe PMC Sign in |
Create an account https://orcid.org Europe PMC Menu About Tools Developers Help Contact …
Create an account https://orcid.org Europe PMC Menu About Tools Developers Help Contact …
[HTML][HTML] Investigating the potential use of chemical biopsy devices to characterize brain tumor lipidomes
The development of a fast and accurate intraoperative method that enables the differentiation
and stratification of cancerous lesions is still a challenging problem in laboratory medicine. …
and stratification of cancerous lesions is still a challenging problem in laboratory medicine. …
[HTML][HTML] Metabolomic phenotyping of gliomas: what can we get with simplified protocol for intact tissue analysis?
…, K Goryński, K Jaroch, D Paczkowski, J Furtak… - Cancers, 2022 - mdpi.com
Simple Summary The diagnostic protocol for gliomas is based on histological examination
and the determination of genetic biomarkers. However, examining molecular biomarkers in …
and the determination of genetic biomarkers. However, examining molecular biomarkers in …
[HTML][HTML] An analysis of the prognostic value of IDH1 (isocitrate dehydrogenase 1) mutation in Polish glioma patients
MA Lewandowska, J Furtak, T Szylberg… - Molecular diagnosis & …, 2014 - Springer
Background and Objective IDH1 (isocitrate dehydrogenase 1) is a potential biomarker and
drug target. Genomic and epigenetic data on astrocytoma have demonstrated that the IDH1 …
drug target. Genomic and epigenetic data on astrocytoma have demonstrated that the IDH1 …